Case 14-2003: A 73-year-old woman with pneumonia and progressive respiratory failure

New England Journal of Medicine

Volumn 348, Issue 19, 2003, Pages 1902-1912

  Waxman, Aaron B ^a,b   Shepard, Jo Anne O ^a,b   Mark, Eugene J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFEPIME; CEFTRIAXONE; FUROSEMIDE; METOPROLOL; NORADRENALIN;

AGED; ANAMNESIS; BRONCHIOLITIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOTRACHEAL TUBE; FEMALE; HUMAN; HYPERTENSION; HYPOXIA; IMAGE ANALYSIS; LEGIONNAIRE DISEASE; NASOGASTRIC TUBE; OXYGEN SATURATION; OXYGEN THERAPY; PATHOLOGICAL ANATOMY; PHYSICAL EXAMINATION; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UREMIA; URINALYSIS; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; LUNG; PATHOLOGY; RADIOGRAPHY;

AGED; BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEGIONNAIRES' DISEASE; LUNG; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY;

EID: 0038077309     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc030009     Document Type: Review

References (27)

1. Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis, and treatment. Am Rev Respir Dis 1990; 142:369-73.
2. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999;160:397-405.
3. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997;157:1453-9.
4. Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae disease in adults: a prospective, population-based surveillance. Ann Intern Med 1992;116:806-12.
5. Fine M, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275:134-41.
6. Pierce AK, Sanford JP. Aerobic gram-negative bacillary pneumonias. Am Rev Respir Dis 1974;110:647-58.
7. Swartz MN. Recognition and management of anthrax - an update. N Engl J Med 2001;345:1621-6. [Erratum, N Engl J Med 2002;346:634.]
8. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch Intern Med 1997;157:1709-18.
9. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 1995;21:Suppl 3:S244-S252.
10. Schlossberg D, Delgado J, Moore MM, Wishner A, Mohn J. An epidemic of avian and human psittacosis. Arch Intern Med 1993;153:2594-6.
11. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985; 64:251-69.
12. Young LS, Bickness DS, Archer BG, et al. Tularemia epidemic: Vermont, 1968: forty-seven cases linked to contact with muskrats. N Engl J Med 1969;280:1253-60.
13. Teursch SM, Martone WJ, Brink EW, et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med 1979;301:826-8.
14. Stout JE, Yu VL. Legionellosis. N Engl J Med 1997;337:682-7.
15. Muder RR, Yu VL, Parry MF. The radiologic manifestations of Legionella pneumonia. Semin Respir Infect 1987;2:242-54.
16. Johnson DH, Cunha BA. Atypical pneumonjas: clinical and extra pulmonary features of Chlamydia, Mycoplasma, and Legionella infections. Postgrad Med 1993;93:69-72, 75-6, 79-82.
17. Kohler RB, Winn WC Jr, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaires disease. J Clin Microbiol 1984;20:605-7.
18. Wright L, King T. Cryptogenic organizing pneumonia (idiopathic bronchiolitis obliterans organizing pneumonia): an update. Clin Pulm Med 1997;4:152-8.
19. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-65.
20. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002;165:983-91.
21. Wyncoll DLA, Evans TW. Acute respiratory distress syndrome. Lancet 1999;354: 497-501.
22. Janz TG, Madan R, Marini JJ, et al. Clinical conference on management dilemmas: progressive infiltrates and respiratory Failure. Chest 2000;117:562-72.
23. Gattinoni L, Bombino M, Pelosi P, et al. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA 1994;271:1772-9.
24. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-49.
25. Tomashefski JF Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11:593-619.
26. Matsubara O, Tamura A, Ohdama S, Mark EJ. Alveolar basement membrane breaks down in diffuse alveolar damage: an immunohistochemical study. Pathol Int 1995;45:473-82.
27. Pache J-C, Christakos PG, Gannon DE, Mitchell JJ, Low RB, Leslie KO. Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol 1998;11:1064-70.